Related Experiment Video

Updated: Mar 30, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

14.7K

Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells

Mathew C Casimiro1, Gabriele Di Sante1, Xiaoming Ju1

  • 1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania. Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania.

Cancer Research
|November 20, 2015
PubMed

Insights

Cyclin D1 enhances DNA damage repair in prostate cancer cells, promoting therapy resistance. Blocking cyclin D1 may offer new strategies to overcome treatment challenges in prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer therapy resistance is linked to elevated cyclin D1 levels.
  • Androgens facilitate DNA repair, and cyclin D1 enhances this DNA damage repair (DDR) process.

Purpose of the Study:

  • To investigate the role of cyclin D1 in androgen-induced DNA damage repair in prostate cancer.
  • To determine if cyclin D1 is essential for the DNA damage response in prostate cancer cells, both in vitro and in vivo.

Main Methods:

  • Utilized established prostate cancer cell lines and prostate tissues from cyclin D1 knockout mice.
  • Assessed DNA damage repair by quantifying γH2AX foci.
  • Performed microarray analysis to examine gene expression changes.

Main Results:

  • Endogenous cyclin D1 reduced dihydrotestosterone (DHT)-dependent γH2AX foci reduction.
  • Cyclin D1 is crucial for androgen-dependent DNA damage response and radioresistance in prostate cancer cells.
  • DHT-induced gene expression changes in prostate cells are largely dependent on cyclin D1.

Conclusions:

  • Cyclin D1 plays a key role in hormone-mediated DNA damage repair and therapy resistance in prostate cancer.
  • Targeting cyclin D1 could be a therapeutic strategy to overcome drug resistance in prostate cancer.
  • Further research is needed to explore alternative therapeutic approaches for prostate cancer to prevent or overcome resistance.

More Related Videos

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry08:21

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry

Published on: September 1, 2019

14.4K
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.7K

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K